Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / COM
-
Number of holders
-
140
-
Total 13F shares, excl. options
-
45,691,884
-
Shares change
-
-368,279
-
Total reported value, excl. options
-
$731,682,748
-
Value change
-
-$7,842,098
-
Put/Call ratio
-
153%
-
Number of buys
-
73
-
Number of sells
-
-74
-
Price
-
$16.01
Significant Holders of AERIE PHARMACEUTICALS INC - COM (AERI) as of Q2 2021
175 filings reported holding AERI - AERIE PHARMACEUTICALS INC - COM as of Q2 2021.
AERIE PHARMACEUTICALS INC - COM (AERI) has 140 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 45,691,884 shares
.
Largest 10 shareholders include VANGUARD GROUP INC (4,349,682 shares), BlackRock Inc. (3,332,409 shares), BANK OF AMERICA CORP /DE/ (2,625,905 shares), WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC (2,186,500 shares), PFM Health Sciences, LP (2,182,684 shares), LOOMIS SAYLES & CO L P (1,872,070 shares), MORGAN STANLEY (1,864,629 shares), AMERIPRISE FINANCIAL INC (1,569,744 shares), SCHRODER INVESTMENT MANAGEMENT GROUP (1,399,345 shares), and GRANAHAN INVESTMENT MANAGEMENT INC/MA (1,387,971 shares).
This table shows the top 140 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.